IL140667A0 - Compositions containing at least one active substance having an influence on the levels of lipids in the blood - Google Patents

Compositions containing at least one active substance having an influence on the levels of lipids in the blood

Info

Publication number
IL140667A0
IL140667A0 IL14066799A IL14066799A IL140667A0 IL 140667 A0 IL140667 A0 IL 140667A0 IL 14066799 A IL14066799 A IL 14066799A IL 14066799 A IL14066799 A IL 14066799A IL 140667 A0 IL140667 A0 IL 140667A0
Authority
IL
Israel
Prior art keywords
lipids
blood
levels
influence
active substance
Prior art date
Application number
IL14066799A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL140667A0 publication Critical patent/IL140667A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
IL14066799A 1998-07-09 1999-07-07 Compositions containing at least one active substance having an influence on the levels of lipids in the blood IL140667A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830732A DE19830732B4 (de) 1998-07-09 1998-07-09 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung
PCT/EP1999/004757 WO2000002541A1 (de) 1998-07-09 1999-07-07 Transdermales pflaster, enthaltend mindestens einen die blutfettwerte beeinflussenden wirkstoff

Publications (1)

Publication Number Publication Date
IL140667A0 true IL140667A0 (en) 2002-02-10

Family

ID=7873488

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14066799A IL140667A0 (en) 1998-07-09 1999-07-07 Compositions containing at least one active substance having an influence on the levels of lipids in the blood
IL140667A IL140667A (en) 1998-07-09 2001-01-01 Preparations containing at least one active substance that have an effect on lipid levels in the blood

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL140667A IL140667A (en) 1998-07-09 2001-01-01 Preparations containing at least one active substance that have an effect on lipid levels in the blood

Country Status (22)

Country Link
EP (1) EP1094797B1 (xx)
JP (1) JP2002520272A (xx)
KR (1) KR100549848B1 (xx)
CN (1) CN1309377C (xx)
AR (1) AR019902A1 (xx)
AT (1) ATE278395T1 (xx)
AU (1) AU770573B2 (xx)
BR (1) BR9911941A (xx)
CA (1) CA2336712C (xx)
CZ (1) CZ300976B6 (xx)
DE (2) DE19830732B4 (xx)
ES (1) ES2230872T3 (xx)
HU (1) HU226614B1 (xx)
IL (2) IL140667A0 (xx)
MX (1) MXPA01000126A (xx)
NZ (1) NZ509215A (xx)
PL (1) PL194983B1 (xx)
RU (1) RU2227023C2 (xx)
TR (1) TR200100021T2 (xx)
TW (1) TWI237572B (xx)
WO (1) WO2000002541A1 (xx)
ZA (1) ZA200100171B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189890B1 (pl) * 1999-09-14 2005-10-31 Kazmierski Jan Zaklad Prod Usl Preparat do ochrony roślin przed chorobami
WO2004026297A1 (ja) * 2002-09-20 2004-04-01 Kowa Co., Ltd. 外用剤
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
CA2511995C (en) * 2003-01-02 2012-03-13 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
EP1731147A4 (en) * 2004-03-31 2010-06-30 Kowa Co EXTERNAL PREPARATION
JP4986411B2 (ja) * 2004-06-01 2012-07-25 久光製薬株式会社 貼付剤
EP1611882B1 (en) 2004-06-01 2010-04-07 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
WO2006002127A1 (en) * 2004-06-21 2006-01-05 Fairfield Clinical Trials, Llc Transdermal delivery system for statin combination therapy
DE102004062182B4 (de) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
JP2009529051A (ja) * 2006-03-07 2009-08-13 オステオスクリーン アイピー， エルエルシー ＨＭＧＣｏ−Ａレダクターゼ阻害剤による骨および軟骨の強化
KR100817274B1 (ko) * 2006-08-21 2008-03-27 삼성전기주식회사 발광 다이오드 패키지 및 그 제조방법
WO2018115535A1 (es) 2016-12-19 2018-06-28 Nutritape, S.L. Parche energizante para deportistas
EP3938076A1 (en) * 2019-03-12 2022-01-19 Corning Incorporated Ceramic honeycomb body with skin
TWI803052B (zh) * 2021-11-12 2023-05-21 佛教慈濟醫療財團法人 經皮遞送裝置及其使用及製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
FR2719220A1 (fr) * 1994-04-29 1995-11-03 Lafon Labor Nouvelle forme galénique pour l'administration transdermique.
EP0782861B1 (en) * 1994-10-05 2001-12-12 Hisamitsu Pharmaceutical Co., Inc. Drug compounding ingredients comprising n-substituted-o-toluidine derivative and percutaneously absorbable preparation
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
EP1028724A1 (en) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans

Also Published As

Publication number Publication date
HUP0102718A3 (en) 2002-12-28
WO2000002541A1 (de) 2000-01-20
CZ300976B6 (cs) 2009-09-30
TWI237572B (en) 2005-08-11
HUP0102718A2 (hu) 2002-03-28
EP1094797A1 (de) 2001-05-02
IL140667A (en) 2007-05-15
PL194983B1 (pl) 2007-07-31
KR100549848B1 (ko) 2006-02-06
CN1309377C (zh) 2007-04-11
ATE278395T1 (de) 2004-10-15
DE19830732B4 (de) 2008-11-13
PL345510A1 (en) 2001-12-17
MXPA01000126A (es) 2002-06-04
CN1308525A (zh) 2001-08-15
CZ200193A3 (en) 2001-05-16
JP2002520272A (ja) 2002-07-09
ES2230872T3 (es) 2005-05-01
CA2336712A1 (en) 2000-01-20
CA2336712C (en) 2008-09-09
RU2227023C2 (ru) 2004-04-20
TR200100021T2 (tr) 2001-05-21
DE19830732A1 (de) 2000-01-13
AU5157499A (en) 2000-02-01
BR9911941A (pt) 2001-03-27
AR019902A1 (es) 2002-03-20
NZ509215A (en) 2003-04-29
EP1094797B1 (de) 2004-10-06
AU770573B2 (en) 2004-02-26
KR20010079513A (ko) 2001-08-22
HU226614B1 (en) 2009-04-28
ZA200100171B (en) 2001-08-10
DE59910758D1 (de) 2004-11-11

Similar Documents

Publication Publication Date Title
IL206621A0 (en) Caspase inhibitors and pharmaceutical compositions containing the same
EP0981649A4 (en) PEPTIDES PROMOTING THE TRANSPORT OF AN ACTIVE AGENT IN TISSUES, COMPOSITIONS CONTAINING THEM AND METHODS OF USE THEREOF
EP0950665A4 (en) PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
HUP0105089A3 (en) Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
HUP0103707A3 (en) Formulation of stable oxalyplatinum solution
PL347310A1 (en) Combination of two or more active ingredients using microencapsulated formulations
ZA992549B (en) Incorporation of active substances in carrier matrixes.
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
HUP0103925A3 (en) Storable active substance concentrate containing formoterol
HUP0004398A3 (en) Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same
SI1419789T1 (sl) Priprava lipidne zmesi in fosfolipidne suspenzije ki vsebuje lipidno zmes in kontrastnih sredstevna osnovi le teh
IL138725A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
IL140667A0 (en) Compositions containing at least one active substance having an influence on the levels of lipids in the blood
ZA994521B (en) Composition containing an opacifier or pearlescent agent and at least one fatty alcohol.
GB9827964D0 (en) Active backplane circuitry
HU9802795D0 (en) Pharmaceutical compositions containing more active components
IL143802A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same
NZ318391A (en) Fungicidal compositions comprising fenazaquine as an active substance
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
IL127439A0 (en) Precipitated silicas which contain an active substance
EP0960885A4 (en) DEPSIPEPTIDES AND MEDICATIONS, WHICH CONTAIN THE SAME AS ACTIVE INGREDIENCIES
SG68529A1 (en) The use of des-aspartate-angiotensin i (agr-val-tyr-ile-his-pro-phe-his-leu) as an anti-cardiac hypertrophic agent
IL137671A0 (en) Semicarbazide derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed